Lv4
485 积分 2021-06-06 加入
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
10天前
已完结
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors
10天前
已完结
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
10天前
已完结
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
10天前
已完结
Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study
10天前
已完结
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
10天前
已完结
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
10天前
已完结
Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline
10天前
已完结
Empagliflozin in Patients with Chronic Kidney Disease
10天前
已完结
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
10天前
已完结
皖公网安备34019202002308
